Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects
Status:
Completed
Trial end date:
2019-08-27
Target enrollment:
Participant gender:
Summary
This study will assess the systemic exposure and pharmacokinetic parameters of SP-103 topical
system following one, two, or three topical system applications and compare to the
pharmacokinetics of ZTlido.